I have noted the following:1)Lotronex results show no statisical benefit for males. Statistical apparently doesn't mean that some males were not helped-- it only means the number was no greater than placebo. 2)Zelnorm studies in Mexico recruited 1500 female and no males.What's going on? Has any chemical/physical explanation been given for the no statistical benefit in males statement for Lotronex? Should Lotronex make it back to the market, will males be excluded from use?Why are males being left out the important Zelnorm studies?What's a male to do?